1.6500 -0.01 (-0.60%)
After hours: 4:01PM EDT
Previous Close | 1.6900 |
Open | 1.6700 |
Bid | 1.6500 x 1000 |
Ask | 1.6900 x 1800 |
Day's Range | 1.6600 - 1.7500 |
52 Week Range | 0.6300 - 5.3600 |
Volume | 123,643 |
Avg. Volume | 377,934 |
Market Cap | 49.119M |
Beta (5Y Monthly) | 1.83 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4760 |
Earnings Date | Mar 24, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the fourth quarter and full year for the period ended December 31, 2020.
NEW YORK, NY / ACCESSWIRE / March 24, 2021 / Navidea Biopharmaceuticals, Inc. (AMEX:NAVB) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 24, 2021 at 5:00 PM Eastern Time.
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will host a conference call and webcast on Wednesday, March 24, 2021 at 5:00 p.m. (EDT) to discuss financial results and corporate developments for the fourth quarter ended December 31, 2020.